Authors
Loading...
NADPH oxidase inhibition merits testing in AF models; leaves open whether it alters human arrhythmia burden or remodeling.
Key points are not available for this paper at this time.
Kim et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: